CD274 and neoplasm: This immunosuppressive environment is compounded by the tumor's low mutational burden (∼0.5 mutations/Mb) compared to cutaneous melanoma (15–30 mutations/Mb), limited neoantigen presentation, and distinct PD-L1 expression patterns (nuclear localization vs. membrane-bound), as detailed in Table 2.